BERTRAND DUBAR

• Designed and executed market analyses for radiopharmaceutical assets quantifying opportunities and
identifying competitive dynamics across US and EU markets.
• Developed long-term revenue forecasts and build market sizing / valuation models to support
strategic investment decisions and product launch
• Prepared and presented board-level materials with recommendations shaping licensing and portfolio
development decisions
• Led cross-functional due diligence to assess partnership opportunities, ensuring strategic and
financial alignment
• Supported group-level strategic initiatives through research, financial modeling and executive
presentations

• Managed 2023-2024 budget and financial reporting (cost tracking, revenue analysis, cash flow
monitoring) with compliance to UEFA and DNCG requirements
• Conducted strategic analysis on revenue streams and expense optimization to support executive
decision-making
• Prepared board-level and external presentations (UEFA, DNCG, new club management) shaping
financial and strategic planning

• Participation in 2 audit missions for banks and financial institutions: Nomura and Euronext
• Analysis and review of companies’ processes (purchasing, sales, cash management, payroll)
• Examination and audit of the companies’ accounting (balance sheet, income statement)